Overweight, obesity, and metabolic syndrome (MetS) have become epidemic conditions
affecting 39%, 13%, and 20% of the population respectively. The aim of this article is to …

Background A cluster of interconnected cardiometabolic risk factors characterizes metabolic
Syndrome (MS). The prevalence of MS is increasing worldwide, but there is not a meta …

Metabolic syndrome (MetS) is a cluster of metabolic risk factors for diabetes, coronary heart
disease, non-alcoholic fatty liver disease, and some tumors. It includes insulin resistance …

Background Cirrhosis is a public health threat associated with high mortality. Alcoholic Liver
Disease (ALD) is the leading cause in Latin America and Metabolic Associated Fatty Liver …

Abstract Introduction and Objectives As of January 2021, over 88 million people have been
infected with COVID-19. Almost two million people have died of severe acute respiratory …

Background Despite the growing evidence of metabolic syndrome as a major risk factor for
cardiovascular and cerebrovascular disease, there are limited studies from India on its …

Lower socio-economic status (SES) is significantly associated with metabolic syndrome
(MS) prevalence, possibly affecting women more than men, although evidence in Spain is …

Background: Metabolic syndrome (MetS) is considerably higher worldwide. It varies greatly
in different populations geographically and based on criteria used to diagnose the disease …

The term metabolic syndrome describes the clinical coexistence of pathological disorders
that can lead to the development of cardiovascular disease and diabetes in the long term …

ABSTRACT Introduction Metabolic syndrome (MetS), ie the cluster of cardiometabolic risk
factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and …